Performance and Safety of the PHENIX LIBERTY, a Medical Device for Electrostimulation and Biofeedback, in the Treatment of Musculoskeletal Disorders
Prospective Evaluation of the Performance and Safety of the PHENIX LIBERTY, a Medical Device for Electrostimulation and Biofeedback, in the Treatment of Locomotor Disorders
1 other identifier
interventional
27
1 country
1
Brief Summary
Evaluate the evolution of locomotor abilities in patients treated with functional electrostimulation and biofeedback (PHENIX LIBERTY VIVALTIS device) for musculoskeletal disorders of the knee and spine. Does the use of the medical device in the treatment of musculoskeletal disorders lead to an improvement ? Participants will use the medical device, which provides electrical stimulation, biofeedback and pressure biofeedback to re-educate the muscles of the knee and spine area and
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedStudy Start
First participant enrolled
August 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2024
CompletedDecember 24, 2024
December 1, 2024
4 months
June 22, 2023
December 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Mean change in Lower Extremity Functional Scale (LEFS) score on the impact of locomotor disorders of the knee
The Lower Extremity Functional Scale (LEFS) is used by physiotherapists and occupational therapists in many clinical settings. It is an English-language measurement tool that collects psychometric data and assesses the functional status of the lower limbs. It consists of 20 questions on the level of difficulty experienced during everyday activities.
At Day 0 and Week 11 (at the end visit within the week after the 12th seance)
Mean change in the Oswestry Disability Index (ODI) score for the impact of locomotor disorders of the spine.
The ODI will be used to assess the disability caused by Lower Back Pain (LBP) The Oswestry Disability Index (ODI), a patient-completed questionnaire that gives a subjective percentage score of the level of function (disability) in activities of daily living in people undergoing rehabilitation after low back pain. The questionnaire examines the level of disability in 10 activities of daily living. Each item consists of 6 statements rated from 0 to 5. With 0 indicating the lowest level of disability and 5 the highest, the total score is calculated as a percentage, with 0% indicating no disability and 100% indicating the highest level of disability.
At Day 0 and Week 11 (at the end visit within the week after the 12th seance)
Secondary Outcomes (13)
Change in patients' visual analog scale (VAS) pain scores for knee pain and/or spine pain at rest and on palpation
At Day 0 and Week 11 (at the end visit within the week after the 12th seance)
Trends in consumption of painkillers and anti-inflammatories
At Day 0 and Week 11 (at the end visit within the week after the 12th seance)
Changes in the rate of improvement of hypertonia of the concerned area (knee or spine) through measurement of myoelectric activity
At Day 0 and Week 11 (at the end visit within the week after the 12th seance)
Changes in the rate of improvement of hypertonia of the concerned area (knee or spine) through Oxford Grading Scale
At Day 0 and Week 11 (at the end visit within the week after the 12th seance)
Changes in the rate of improvement in awakening and muscle strengthening through Oxford grading scale
At Day 0 and Week 11 (at the end visit within the week after the 12th seance)
- +8 more secondary outcomes
Study Arms (1)
Standard of care plus additional questionaire
OTHERAs part of this clinical investigation, the medical device under investigation is used in accordance with its usual use, and the patient's therapeutic procedure includes additional, non-invasive procedures. These additional procedures relate to the addition of an endof- life visit and validated questionnaires assessing functional deficiencies and impact on daily life.
Interventions
12 sessions of electrical stimulation and biofeedback performed between 6 and 8 weeks at regular intervals according to a schedule drawn up by the physiotherapist. The patient will undergo 12 therapeutic functional reeducation sessions, at regular intervals according to a schedule drawn up by the physiotherapist, during which the PHENIX LIBERTY device may be used. The patients will complete questionnaires at the end of the care. Overall, the functional rehabilitation sessions will include muscle testing, electrostimulation and biofeedback. The follow up will be conduct as follow : * 12 sessions between 6 and 8 weeks * 1 end visit, within the week after the 12th session
Eligibility Criteria
You may qualify if:
- Adult patients (between 18 and 65 years of age);
- Patient presenting at least one of the following symptoms related to a locomotor disorder of the knee and/or spine: pain, hypertonia, amyotrophy, mobility restriction, muscle weakness, reduction or loss of motor control, reduction in motor pattern, trophic anomaly;
- Patient able to make himself available to attend sessions regularly and is confident of being able to complete all sessions; ;
- Patient who has signed the study participation consent form;y;
- Patient physically and mentally willing and able, according to the investigator's judgment at the time of recruitment, to perform the procedures under study;
- Patient with social security coverage.
You may not qualify if:
- Patients with Stroke, Alzheimer's, multiple sclerosis, peripheral nervous system disorders, spinal cord injury or with cognitive and/or behavioural disorders likely, in the practitioner's judgement in the practitioner's judgement, interact with the self-assessment or biofeedback;
- Patients with hypersensitivity to electrostimulation;
- Patients with an implanted pacemaker or spinal cord pacemaker;
- Patients who have renounced their liberty by administrative or judicial sentence, or under guardianship or limited judicial protection;
- Patient unable to read or write French;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vivaltislead
- CEISOcollaborator
- Human Physiocollaborator
Study Sites (1)
Human Physio
Nîmes, 30000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mathias Willame
Human Physio
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2023
First Posted
July 3, 2023
Study Start
August 19, 2024
Primary Completion
December 18, 2024
Study Completion
December 18, 2024
Last Updated
December 24, 2024
Record last verified: 2024-12